During the last two decades, highly variable levels of HLA-G neo-expression leading not only to escape from immune surveillance, but also to tolerogenic responses of transplants have been described in different neoplasms, autoimmune, and inflammatory diseases as well as upon pathogen infection by parasites, bacteria, and viruses [26–35]. This evidence concerns the gene HLA-G and neoplasm.